{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-015362","form_type":"8-K","ticker":"PAHC","cik":"0001069899","company_name":"PHIBRO ANIMAL HEALTH CORP","filed_at":"2023-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.069915+00:00","generated_at":"2026-06-11T01:47:20.321670+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Phibro Q4 adj diluted EPS up 5% to $0.38; full-year net income down 34%","bullets":["Q4 net sales $255.0M (flat YoY); net income $11.5M (+54%); adj diluted EPS $0.38 (+5%).","FY2023 net sales $977.9M (+4%); net income $32.6M (-34%); adj diluted EPS $1.21 (-8%).","FY2024 guidance: net sales $1.0-1.05B; adj EBITDA $115-121M; adj diluted EPS $1.12-1.27.","Animal Health FY sales +9% to $659.9M; Mineral Nutrition -6%; gross leverage 4.2x.","Free cash flow negative $24M; liquidity $248M; pension settlement to incur ~$10.4M expense in Q1 FY2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-015362","json":"https://secwatch.observer/filing/0001558370-23-015362.json","markdown":"https://secwatch.observer/filing/0001558370-23-015362.md","text":"https://secwatch.observer/filing/0001558370-23-015362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069899/000155837023015362/0001558370-23-015362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069899/000155837023015362/pahc-20230830x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T01:47:20.321670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"acd140e0463b41a605f1dc85b7bf3fe506162f0b","claim":"PHIBRO ANIMAL HEALTH CORP updated its the fiscal quarter and fiscal year ended June 30, 2023 guidance (initiated).","evidence_excerpt":"Phibro Animal Health Corporation issued a press release announcing its operating results for the fiscal quarter and fiscal year ended June 30, 2023 and its financial guidance for the fiscal year ending June 30, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1069899/000155837023015362/0001558370-23-015362-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter and fiscal year ended June 30, 2023"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}